These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10155288)
1. How much faith can we have in pharmacoeconomic analyses? Hatoum HT; Kong SX Pharmacoeconomics; 1994 Dec; 6(6):584-6. PubMed ID: 10155288 [No Abstract] [Full Text] [Related]
2. Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol. Bentkover JD; Baker AM; Kaplan H Pharmacoeconomics; 1994 Apr; 5(4):335-42. PubMed ID: 10160575 [TBL] [Abstract][Full Text] [Related]
3. A decision analysis model in the evaluation of NSAIDs in a managed care setting: a case study. Brixner DI Med Interface; 1994 Nov; 7(11):145-50. PubMed ID: 10138701 [TBL] [Abstract][Full Text] [Related]
4. Nabumetone--a new NSAID. Med Lett Drugs Ther; 1992 Apr; 34(868):38-40. PubMed ID: 1556995 [No Abstract] [Full Text] [Related]
6. A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa. Roth SH; Tindall EA; Jain AK; McMahon FG; April PA; Bockow BI; Cohen SB; Fleischmann RM Arch Intern Med; 1993 Nov; 153(22):2565-71. PubMed ID: 8239849 [TBL] [Abstract][Full Text] [Related]
7. [Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs]. Shi W; Wang YM; Cheng NN; Chen BY; Li D Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1044-8. PubMed ID: 14687510 [TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal medications and procedures in osteoarthritis patients treated with rofecoxib compared with nonselective NSAIDs. Watson DJ; Harper SE; Zhao PL; Bolognese JA; Simon TJ MedGenMed; 2001 Nov; 3(4):6. PubMed ID: 11965201 [TBL] [Abstract][Full Text] [Related]
9. Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs. Barradell LB; Whittington R; Benfield P Pharmacoeconomics; 1993 Feb; 3(2):140-71. PubMed ID: 10146962 [TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomic factors related to the treatment of schizophrenia. Concluding discussion. J Clin Psychiatry; 1999; 60 Suppl 3():59-60. PubMed ID: 10073380 [No Abstract] [Full Text] [Related]
11. Analgesic activity of nabumetone versus naproxen in acute exacerbation of osteoarthritis. A short term study. Cazzola M; Montrone F; Azzolini V; Vaiani G; Caruso I Drugs; 1990; 40 Suppl 5():78-9. PubMed ID: 2081501 [No Abstract] [Full Text] [Related]
14. Economic evaluation of prophylactic treatment with Misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium. Carrin GJ; Torfs KE Rev Epidemiol Sante Publique; 1990; 38(3):187-99. PubMed ID: 2118670 [TBL] [Abstract][Full Text] [Related]
15. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis. Roth SH Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889 [TBL] [Abstract][Full Text] [Related]
16. A controlled comparison of tiaprofenic acid and ibuprofen in osteoarthritis. Lambert JR; Cardoe N; Simpson NR; Oldham P; Nichol PE; Martin L Int J Clin Pharmacol Res; 1985; 5(3):161-4. PubMed ID: 3894258 [TBL] [Abstract][Full Text] [Related]
18. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions. Davis R; Yarker YE; Goa KL Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992 [TBL] [Abstract][Full Text] [Related]
19. [Economic evaluation of the use of diclofenac/misoprostol in the treatment of osteoarticular diseases]. Soto Alvarez J An Med Interna; 2000 Sep; 17(9):477-84. PubMed ID: 11100534 [TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy. Walan A; Wahlqvist P Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]